Cepheid (CPHD) Receives FDA Emergency Use Authorization for Xpert Ebola as Zaire Virus Diagnostic
Tweet Send to a Friend
Cepheid (NASDAQ: CPHD) announced it has received Emergency Use Authorization from the U.S. Food & Drug Administration (FDA) for Xpert ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
